BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+6.18%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.6B
AUM Growth
+$17.6B
(+1.3%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
87.48%
Holding
123
New
5
Increased
24
Reduced
7
Closed
6
Top Buys
| 1 |
Replimune Group
REPL
|
$34.6M |
| 2 |
Ascendis Pharma
ASND
|
$28.9M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$21.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$19.9M |
| 5 |
Nurix Therapeutics
NRIX
|
$18.1M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$63.5M |
| 2 |
Legend Biotech
LEGN
|
$63.4M |
| 3 |
Axsome Therapeutics
AXSM
|
$25.3M |
| 4 |
Merus
MRUS
|
$23.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$9.64M |
Sector Composition
| 1 | Healthcare | 99.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.3B | 47.09% | 46,912,266 | – | – |
|
2
Incyte
INCY
$16.5B
| $2.75B | 15.58% | 36,154,117 +433 | +0% | +$32.9K |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.89B | 10.71% | 11,668,897 | – | – |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $632M | 3.58% | 7,620,494 | – | – |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $591M | 3.35% | 41,923,486 +12,782 | +0% | +$180K |
|
|
6
Ascendis Pharma
ASND
$11.8B
| $451M | 2.56% | 4,852,655 +311,051 | +7% | +$28.9M |
|
7
argenx
ARGX
$43.6B
| $424M | 2.41% | 1,119,557 | – | – |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $134M | 0.76% | 12,710,818 | – | – |
|
9
Kodiak Sciences
KOD
$478M
| $132M | 0.75% | 17,310,490 +1,379,445 | +9% | +$10.5M |
|
|
GBT
10
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $119M | 0.68% | 3,732,502 +417,737 | +13% | +$13.3M |
|
11
AbCellera Biologics
ABCL
$1.25B
| $111M | 0.63% | 10,450,180 | – | – |
|
12
Madrigal Pharmaceuticals
MDGL
$9.76B
| $107M | 0.61% | 1,499,213 | – | – |
|
|
MRTX
13
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $94.6M | 0.54% | 1,409,784 | – | – |
|
14
Immunocore
IMCR
$1.62B
| $94M | 0.53% | 2,520,730 | – | – |
|
|
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $91.6M | 0.52% | 1,148,504 +249,662 | +28% | +$19.9M |
|
16
Cerus
CERS
$251M
| $85M | 0.48% | 16,067,558 +2,354,363 | +17% | +$12.5M |
|
17
Travere Therapeutics
TVTX
$1.56B
| $80M | 0.45% | 3,300,009 | – | – |
|
|
18
Replimune Group
REPL
$422M
| $62.8M | 0.36% | 3,591,081 +1,979,378 | +123% | +$34.6M |
|
19
Entrada Therapeutics
TRDA
$208M
| $59.3M | 0.34% | 4,865,819 +161,400 | +3% | +$1.97M |
|
|
IGMS
20
DELISTED
IGM Biosciences
IGMS
| $56.9M | 0.32% | 3,156,102 | – | – |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $56.7M | 0.32% | 2,879,825 +495,083 | +21% | +$9.75M |
|
22
Krystal Biotech
KRYS
$4.27B
| $53M | 0.3% | 807,735 | – | – |
|
23
Prelude Therapeutics
PRLD
$68.5M
| $52.8M | 0.3% | 10,123,824 | – | – |
|
|
24
Nurix Therapeutics
NRIX
$714M
| $49.2M | 0.28% | 3,882,125 +1,428,043 | +58% | +$18.1M |
|
|
25
Legend Biotech
LEGN
$6.41B
| $47.1M | 0.27% | 856,658 -1,152,341 | -57% | -$63.4M |
|